The fourth edition of the clinical summary of emergency contraceptive pills (ECP) provides a two-page overview of ICEC’s Medical and Service Delivery Guidance. New information on the hormone UPA and new studies on the influence of BMI on effectiveness are briefly discussed, as well as how ECP regimens work, their efficacy and safety, guidelines on repeat use, and considerations for starting or resuming regular contraceptives following ECP regimens.
This section contains fact sheets, blog posts, technical statements, clinical guidelines, journal articles and publications focusing on policies and access. Several publications focus on sexual assault and humanitarian settings. For more information on specific themes, please visit the EC Issues Pages. Many of our publications are available in multiple languages.
Updated in 2018, the Medical and Service Delivery Guidance is ICEC’s most widely distributed publication. Designed to serve as a key reference and training document for service provision, it includes a range of medical and service delivery issues in an easy to use format, from screening, dosages, and counseling to EC pill regimens. Local programs can adapt this guidance as necessary to comply with national or other requirements.
This paper, co-authored by ICEC and Catholics for Choice, details how Catholic bishops continue to oppose access to emergency contraception (EC) and lead opposition efforts, going against the beliefs of the majority of their constituents. In the United States and around the world, the church hierarchy has opposed EC access through public statements, involvement in legal cases, and threats to excommunicate women who use EC. This paper outlines the issues and provides examples of Catholic hierarchy opposition from around the world, and how advocates, policymakers, and healthcare professionals are fighting back.
This article discusses low global knowledge and use of EC and the role of the media in perpetuating misperceptions about EC. It encourages advocates to be prepared with the facts about EC to counter these myths. Authors: Elizabeth Westley and Anna Glasier
This article reviews published literature and websites of national organizations dedicated to EC to provide an update to pharmacists on EC. It highlights the unique role that pharmacists play in providing information access to EC to patients and provides technical information regarding EC including EC methods available in the U.S., effectiveness and safety, and the mechanism of action, as well as information on the impact of risk taking and unintended pregnancy, barriers to access, and over-the-counter regulatory availability. Authors: Linda Dominguez, Donald F. Downing, Beth Jordan, Deborah Kurnik, Eleanor B. Schwarz, James Trussell, and Elizabeth Westley
Emergency contraception has been in use for decades and its safety is well established through monitoring and studies. This fact sheet, produced jointly with the World Health Organization, the International Federation of Obstetrics and Gynecology, and the International Planned Parenthood Federation, is based on a thorough reading of the literature and extensive technical review by medical experts from around the world.
This article responds to analyses suggesting that EC is not as effective in reducing unwanted pregnancy rates at a population level as once hoped, and to the argument that women are “abusing” EC by using it repeatedly instead of using other more effective methods. The authors’ respond that EC still fills a unique and important role in the mix of available contraceptive methods, that it is effective enough to be promoted as a contraceptive option, and that women’s use of the method does not constitute a problem but rather contributes in a positive way to every woman’s challenge of how to avoid unplanned pregnancies. Authors: Francine Coeytaux, Elisa S. Wells, and Elizabeth Westley
Mexico was one of the earliest countries working to expand EC access. Partners came together to pursue a synergistic four-pronged strategy, including product registration, health care provider training and orientation, awareness raising among the general public, and policy change. By 2006, five EC products were registered and sold in Mexico, EC was widely available through pharmacies and included in the public sector contraceptive options, and knowledge of the method had increased substantially. Authors: Raffaela Schiavon and Elizabeth Westley
Although EC is safe and has the potential to prevent unwanted pregnancies, its use remains low in most settings, due to a range of barriers to access. This paper reviews key issues related to EC and describes recommendations reached during the Women’s Health Alliance pre-Congress workshop, held in advance of the International Federation of Gynecology and Obstetrics (FIGO) 2006 World Congress. The working group concluded that national societies of obstetrics and gynecology can play an important role in increasing access to this unique contraceptive method. Authors: Elizabeth Westley, Helena von Hertzen, and Anibal Faundes
This article reviews a comparison of women who enroll in emergency contraception (EC) trials with those who decline and seeks to understand why eligible women decline to participate. Data were collected from nearly 6,000 women seeking EC at three clinics in the USA and UK during a period of nearly 1 year (from September 1997 to August 1998). The study found that women in EC trials are likely to face higher pregnancy risk than the general population. Authors: Elizabeth Westley, Alison Bigrigg, Anne Webb, Sue Haskell, Kelly Blanchard, Becca Loftus-Granberg, Annik Sorhaindo, Karen Johnston, Aileen Spiers, Katrina Abuabara, Charlotte Ellertson
ICEC provides guidance for adapting materials, taking into account such issues as local culture, language and literacy levels; local misperceptions or misinformation about EC; products used and distribution mechanisms.
Consortium members developed a 9-step framework for introducing EC into national programs, describing a carefully planned process designed to be participatory and responsive to client needs.